Go to home page - PHARMAC - Pharmaceutical Management Agency
Leading Edge Medicines Management home

This is the text extract for 2010-03 Schedule Dispatch , browse documents here.


18 February 2010 March 2010 Pharmaceutical Schedule Dispatch This document is provided to pharmacists as an early notification of the changes to be announced in the March 2010 Update to the Pharmaceutical Schedule. Please notify PHARMAC (0800 66 00 50) to change or remove your contact details.

New listings  Vitamins (Vitabdeck) cap (fat soluble vitamins A, D, E, K) – Special Authority – retail pharmacy (p’code 2253801)  Crotamiton (Itch-Soothe) crm 10% - only on a prescription and not in combination (p’code 2343614)  Chlorhexidine gluconate (healthE) handrub 1% with ethanol 70% - subsidy by endorsement – not more than 500 ml per month (p’code 2318679)  Pregnancy tests – hCG urine (Innovacon hCG One Step Pregnancy Test Device) cassette – only on a PSO, up to 200 test available on a PSO (p’code 2349647)  Influenza vaccine (Influvac) inj – Hospital pharmacy [Xpharm] (p’code 2186454)  Megestrol acetate (Apo-Megestrol) tab 160 mg – Retail pharmacy-Specialist (p’code 2261499) Changes to restrictions  Ursodeoxycholic acid (Actigall) cap 300 mg – amended Special Authority criteria  Diltiazem hydrochloride (Cardizem CD) cap long-acting 120 mg – amended presentation description  Nicotine (Habitrol and Nicotinell) gum 2 mg and 4 mg (fruit and mint) – maximum per dispensing cannot be waived via Access Exemption criteria  Nicotine (Habitrol) lozenge 1 mg and 2 mg – maximum per dispensing can not be waived via Access Exemption criteria  Nicotine (Habitrol) patch 7 mg, 14 mg and 21 mg – maximum per dispensing can not be waived via Access Exemption criteria  Influenza vaccine (Fluvax, Fluarix, Influvac and Vaxigrip) inj – amended access criteria  Trifluoperazine hydrochloride (Stelazine) tab 1 mg, 2 mg and 5 mg – removal of Section 29 criteria Increased subsidy

Chemical Apomorphine hydrochloride Lithium carbonate Lorazepam Sulphasalazine Presentation Inj 10 mg per ml, 2 ml Tab long-acting 400 mg Tab 1 mg Tab 2.5 mg Tab 500 mg Tab EC 500 mg Fully brands subsidised

Apomine Priadel Ativan Ativan Salazopyrin Salazopyrin EN

Decreased subsidy

Chemical Paracetamol with codeine Presentation Tab paracetamol 500 mg with codeine phosphate 8 mg Fully brands ParaCode subsidised Partially brands Codalgin subsidised

NB. For the magnitude of the above subsidy changes, please consult the online version of the Update to the Pharmaceutical Schedule at: www.pharmac.govt.nz/healthpros/Schedule

A336978 Page 1 of 1

Metadata

Title

2010-03 Schedule Dispatch

Abstract

18 February 2010 March 2010 Pharmaceutical Schedule Dispatch This document is provided to pharmacists as an early notification of the changes to be announced in the March 2010 Update to the Pharmaceutical Schedule. Please notify PHARMAC (0800 66 00 50)…

Page 1

icon

Note

This text has been extracted from the source PDF document.

Also available as plain text.

Please contact webmaster to discuss alternative format options.